Organ damage in patients with incomplete lupus syndromes: from a Chinese academic center

Clinical Rheumatology

Volumn 34, Issue 8, 2015, Pages 1383-1389

  Chen, Zhen ^a,b,c   Li, Meng Tao ^a,b   Xu, Dong ^a,b   Leng, Xiao Mei ^a,b   Wang, Qian ^a,b   Tian, Xin Ping ^a,b   Zhang, Shang Zhu ^a,b   Zhao, Yan ^a,b   Zeng, Xiao Feng ^a,b  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

Autoantibodies; Damage; Incomplete SLE; SDI; Systemic lupus erythematosus

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTHRITIS; ARTICLE; BLOOD VESSEL INJURY; CHINESE; CLINICAL FEATURE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE COURSE; DISEASE DURATION; FEMALE; GASTROINTESTINAL DISEASE; HUMAN; INCOMPLETE LUPUS SYNDROME; INFLAMMATION; KIDNEY DISEASE; LUNG INJURY; LUPUS ERYTHEMATOSUS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MUSCULOSKELETAL INJURY; ORGAN INJURY; PRIORITY JOURNAL; PROTEIN LOSING GASTROENTEROPATHY; PULMONARY HYPERTENSION; RETROSPECTIVE STUDY; SLEDAI; SYSTEMIC LUPUS ERYTHEMATOSUS; AGE; BRAIN; CHINA; KIDNEY; LUNG; MIDDLE AGED; PATHOLOGY; SEVERITY OF ILLNESS INDEX; SYNDROME; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; BRAIN; CHINA; FEMALE; HUMANS; KIDNEY; LUNG; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SYNDROME; YOUNG ADULT;

EID: 84938748807     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-015-2884-3     Document Type: Article

References (28)

1. Hochberg MC (1997) for the Diagnostic and Therapeutic Criteria Committee of the American College of Rheumatology. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 40:1725
2. Vila LM, Mayor AM, Valentin AH, Garcia-Soberal M, Vila S (2000) Clinical outcome and predictors of disease evolution in patients with incomplete lupus erythematosus. Lupus 9:110–115
3. Gómez-Puerta JA, Martín H, Amigo MC, Aguirre MA, Camps MT, Cuadrado MJ, Hughes GR, Khamashta MA (2005) Long-term follow-up in 128 patients with primary antiphospholipid syndrome: do they develop lupus? Medicine (Baltimore) 84:225–230
4. Olsen NJ, Yousif M, Mutwally A, Cory M, Elmagboul N, Karp DR (2013) Organ damage in high-risk patients with systemic and incomplete lupus syndromes. Rheumatol Int 33(10):2585–2590
5. Li QZ, Zhou J, Lian Y, Zhang B, Branch VK, Carr-Johnson F, Karp DR, Mohan C, Wakeland EK, Olsen NJ (2010) Interferon signature gene expression is correlated with autoantibody profiles in patients with incomplete lupus syndromes. Clin Exp Immunol 159(3):281–291
6. Swaak AJ, van de Brink H, Smeenk RJ, Manger K, Kalden JR, Tosi S, Marchesoni A, Domljan Z, Rozman B, Logar D, Pokorny G, Kovacs L, Kovacs A, Vlachoyiannopoulos PG, Moutsopoulos HM, Chwalinska-Sadowska H, Dratwianka B, Kiss E, Cikes N, Anic B, Schneider M, Fischer R, Bombardieri S, Mosca M, Graninger W, Smolen JS (2001) Incomplete lupus erythematosus: results of a multicentre study under the supervision of the EULAR Standing Committee on International Clinical Studies Including Therapeutic Trials (ESCISIT). Rheumatology (Oxford) 40:89–94
7. Hallengren CS, Nived O, Sturfelt G (2004) Outcome of incomplete systemic lupus erythematosus after 10 years. Lupus 13(2):85–88
8. Fabio G, Carrabba M, Hu C, Floriani M, Besana C (2005) Dramatic development of severe SLE in a patient with an incomplete disease. Rheumatol Int 25:543–547
9. Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M, Bacon P, Bombardieri S, Hanly J, Hay E, Isenberg D, Jones J, Kalunian K, Maddison P, Nived O, Petri M, Richter M, Sanchez-Guerrero J, Snaith M, Sturfelt G, Symmons D, Zoma A (1996) The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index for systemic lupus erythematosus. Arthritis Rheum 39:363–369
10. Li M, Zhang W, Leng X, Li Z, Ye Z, Li C, Li X, Zhu P, Wang Z, Zheng Y, Li X, Zhang M, Zhang F, Zhao Y, Zeng X (2013) CSTAR co-authors. Chinese SLE Treatment and Research group (CSTAR) registry: I. Major clinical characteristics of Chinese patients with systemic lupus erythematosus. Lupus 22(11):1192–1199
11. Gladman DD, Goldsmith CH, Urowitz MB, Bacon P, Bombardier C, Isenberg D, Kalunian K, Liang MH, Maddison P, Nived O (1994) Sensitivity to change of 3 systemic lupus erythematosus disease activity indices: international validation. J Rheumatol 21:1468–1471
12. Mosca M, Tani C, Talarico R, Bombardieri S (2011) Undifferentiated connective tissue diseases (UCTD): simplified systemic autoimmune diseases. Autoimmun Rev 10(5):256–258
13. Mosca M, Tani C, Carli L, Bombardieri S (2012) Undifferentiated CTD: a wide spectrum of autoimmune diseases. Best Pract Res Clin Rheumatol 26(1):73–77
14. Laustrup H, Voss A, Green A, Junker P (2010) SLE disease patterns in a Danish population-based lupus cohort: an 8-year prospective study. Lupus 19:239–246
15. Vila LM, Mayor AM, Valentin AH, Garcia-Soberal M, Vila S (2000) Clinical outcome and predictors of disease evolution in patients with incomplete lupus erythematosus. Lupus 9:110–115
16. Bodolay E, Csiki Z, Szekanecz Z, Ben T, Kiss E, Zeher M, Szücs G, Dankó K, Szegedi G (2003) Five-year follow-up of 665 Hungarian patients with undifferentiated connective tissue disease (UCTD). Clin Exp Rheumatol 21:313–320
17. Kuan W, Li E, Tam LS (2010) Lupus organ damage: what is damaged in Asian patients? Lupus 19(12):1436–1441
18. Tam LS, Wong A, Mok VC, Zhu YE, Kwok LW, Li TK, Wong KC, Li EK (2008) The relationship between neuropsychiatric, clinical, and laboratory variables and quality of life of Chinese patients with systemic lupus erythematosus. J Rheumatol 35:1038–1045
19. Rahman P, Gladman DD, Urowitz MB, Hallet D, Tam LS (2001) Early damage as measured by the SLICC/ACR damage index is a predictor of mortality in systemic lupus erythematosus. Lupus 10:93–96
20. Mok CC, Ho CT, Wong RW, Lau CS (2003) Damage accrual in southern Chinese patients with systemic lupus erythematosus. J Rheumatol 30:1513–1519
21. Petri M, Orbai AM, Alarcón GS, Gordon C, Merrill JT, Fortin PR, Bruce IN, Isenberg D, Wallace DJ, Nived O, Sturfelt G, Ramsey-Goldman R, Bae SC, Hanly JG, Sánchez-Guerrero J, Clarke A, Aranow C, Manzi S, Urowitz M, Gladman D, Kalunian K, Costner M, Werth VP, Zoma A, Bernatsky S, Ruiz-Irastorza G, Khamashta MA, Jacobsen S, Buyon JP, Maddison P, Dooley MA, van Vollenhoven RF, Ginzler E, Stoll T, Peschken C, Jorizzo JL, Callen JP, Lim SS, Fessler BJ, Inanc M, Kamen DL, Rahman A, Steinsson K, Franks AG Jr, Sigler L, Hameed S, Fang H, Pham N, Brey R, Weisman MH, McGwin G Jr, Magder LS (2012) Derivation and validation of the Systemic Lupus International Collaborating Clinics Classification Criteria for systemic lupus erythematosus. Arthritis Rheum 64(8):2677–2686
22. Petri M, Purvey S, Fang H, Magder LS (2012) Predictors of organ damage in systemic lupus erythematosus: the Hopkins Lupus Cohort. Arthritis Rheum 64(12):4021–4028
23. Sung YK, Hur NW, Sinskey JL, Park D, Bae SC (2007) Assessment of damage in Korean patients with systemic lupus erythematosus. J Rheumatol 34:987–991
24. Molad Y, Gorshtein A, Wysenbeek AJ, Guedj D, Majadla R, Weinberger A, Amit-Vazina M (2002) Protective effect of hydroxychloroquine in systemic lupus erythematosus. Prospective long-term study of an Israeli cohort. Lupus 11:356–361
25. Alarcón GS, Roseman JM, McGwin G Jr, Uribe A, Bastian HM, Fessler BJ, Baethge BA, Friedman AW, Reveille JD, LUMINA Study Group (2004) Systemic lupus erythematosus in three ethnic groups. XX. Damage as a predictor of further damage. Rheumatology 43:202–205
26. Maddison P, Farewell V, Isenberg D, Aranow C, Bae SC, Barr S, Buyon J, Fortin P, Ginzler E, Gladman D, Hanly J, Manzi S, Nived O, Petri M, Ramsey-Goldman R, Sturfelt G, Systemic LupusInternational Collaborating Clinics (2002) The rate and pattern of organ damage in late onset systemic lupus erythematosus. J Rheumatol 29:913–917
27. Sutton EJ, Davidson JE, Bruce IN (2013) The systemic lupus international collaborating clinics (SLICC) damage index: a systematic literature review. Semin Arthritis Rheum 43:352–361
28. Stoll T, Sutcliffe N, Mach J, Klaghofer R, Isenberg DA (2004) Analysis of the relationship between disease activity and damage in patients with systemic lupus erythematosus—a 5-yr prospective study. Rheumatology 43:1039–1044